Zach Daftary

Zach Daftary is a seasoned professional with extensive experience in strategy and consulting, currently serving as a Senior Strategy Analyst in Risk Adjustment and previously as a Senior Enterprise Effectiveness Consultant at Highmark Health since July 2019. At Highmark, contributions included developing strategic plans that generated approximately $200 million annually in bonus revenue for Medicare Advantage plans. Prior roles included various commercial strategy functions at Symmetry Surgical, where Zach managed M&A integration and analyzed financial implications, as well as strategic consulting at Moffitt Cancer Center. Zach's earlier experience includes leadership in prime brokerage settlements at UBS and corporate actions at BNY Mellon. Educational credentials include an MBA from Indiana University and a BA in Economics and German from the University of Pittsburgh.